Recent Finacing
Recent Raise
Proniras is a Seattle-based biotechnology startup developing tezampanel, a novel drug candidate for treating seizures and potential nerve-agent poisoning.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Proniras.
